Klaviyo director Oulman proposes $285K share sale
The listed shares stem from two restricted-stock vesting events in May and June 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Klaviyo, Inc. director Roxanne Oulman reported a proposed sale of 13,989 Series A securities through Fidelity Brokerage Services LLC, with an aggregate market value of $284,825.08 and an approximate sale date of November 6, 2026. The reported securities stem from restricted stock vesting: 8,169 shares on May 15, 2026, and 5,820 shares on June 9, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did Roxanne Oulman acquire the KVYO securities listed for sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.